Eargo Inc. (EAR): Price and Financial Metrics

Eargo Inc. (EAR): $0.97

-0.08 (-7.42%)

POWR Rating

Component Grades













EAR Stock Price Chart Interactive Chart >

Price chart for EAR

EAR Price/Volume Stats

Current price $0.97 52-week high $40.21
Prev. close $1.05 52-week low $0.95
Day low $0.95 Volume 1,478,500
Day high $1.06 Avg. volume 2,172,184
50-day MA $1.98 Dividend yield N/A
200-day MA $5.40 Market Cap 38.26M

Eargo Inc. (EAR) Company Bio

Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.

EAR Latest News Stream

Event/Time News Detail
Loading, please wait...

EAR Latest Social Stream

Loading social stream, please wait...

View Full EAR Social Stream

Latest EAR News From Around the Web

Below are the latest news stories about Eargo Inc that investors may wish to consider to help them evaluate EAR as an investment opportunity.

Volatility Of Eargo Inc. (EAR) Reaches 7.56%: Make Sure To Keep Your Seat Tight!

Eargo Inc. (NASDAQ:EAR) concluded the trading at $5.07 on Friday, February 04 with a rise of 5.19% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.82 with its price kept floating in the range of $4.77 and $5.15 on the day. … Volatility Of Eargo Inc. (EAR) Reaches 7.56%: Make Sure To Keep Your Seat Tight! Read More »

Stocks Register | February 5, 2022

Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA

SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR ), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule to create a new regulatory category of over the counter (OTC) hearing aids. Eargo is supportive of the FDA''s proposed rule and applauds the FDA''s efforts to broaden consumer access to hearing technology. Historically, most people with hearing loss who would benefit from wearing a hearing aid have never used them, even though unaddressed hearing loss is associated with significant negative health outcomes and increased costs. 1 , 2 Eargo believes the FDA''s efforts to establish a regulatory f...

Benzinga | January 20, 2022

BBBY Stock Alert: Why Bed Bath & Beyond Is the No. 1 Trending Ticker Today

Bed Bath & Beyond (BBBY) stock is on the rise today as the shares trend following the release of its fiscal Q3 2021 earnings report.

William White on InvestorPlace | January 6, 2022

EAR Stock: The DOJ News That Has Eargo Investors Hearing ‘Cha-Ching!’ Today

Eargo (EAR) stock is rocketing higher on Thursday thanks to news from the DOJ concerning an investigation into the company.

William White on InvestorPlace | January 6, 2022

Eargos new hearing aids can automatically adjust to your environment

Eargo has been making smart hearing aids for a while, but its sixth-generation device adds automatic sound adjustment depending on a users environment. It comes at a time where more companies are investing in sound boosting tech and the FDA has proposed a rule to establish a new over-the-counter hearing aid category to make the devices more accessible.

The Verge | January 6, 2022

Read More 'EAR' Stories Here

EAR Price Returns

1-mo N/A
3-mo -81.66%
6-mo -80.98%
1-year -97.56%
3-year N/A
5-year N/A
YTD -80.98%
2021 -88.62%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4178 seconds.